1) U.S. Preventive Services Task Force:Screening for prostate cancer:Recommendation and rationale. Ann Intern Med 137:915-916, 2002
2) Harris R, et al:Screening for Prostate Cancer;An Update of the Evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:917-929, 2002
3) Bill-Axelson A, et al:Scandinavian Prostate Cancer Group Study No.4. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352:1977-1984, 2005
4) Johansson JE, et al:Natural history of early, localized prostate cancer. JAMA 291(22):2713-2719, 2004
5) Albertsen PC, et al:20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293(17):2095-2101, 2005
6) Sheridan, et al:Shared decision making about screening and chemoprevention. Am J Prev Med 26(1):56-66, 2004
7) Labrie F, et al:Screening decreases prostate cancer mortality:11-year follow-up of the 1988 Quebec prospective randomized controlled trial. Prostate 59(3):311-318, 2004
8) Aus G, et al:Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer―results from a prospective, population-based randomized controlled trial. Eur Urol 51(3):659-664, 2007
9) Hankey BF, et al:Cancer Surveillance Series:Interpreting Trends in Prostate Cancer Part I:Evidence of the Effects of screening in Recent Prostate Cancer Incidence, Mortality, and Survival Rates. J Natl Cancer Inst 91:1017-1024, 1999
10) Stone NN, et al:Screening for prostate cancer by digital rectal examination and prostate-specific antigen:Results of Prostate Cancer Awareness week, 1989-1992. Urology Symposium 44:18-25, 1994
11) 平成19年度厚生労働省がん研究助成金:がん検診の適切な方法とその評価法の確立に関する研究班(主任研究者/濱島ちさと):有効性評価に基づく前立腺がん検診ガイドライン,2008